Rocket Doctor AI Inc, formerly known as Treatment.com AI Inc., is an American company listed on the OTC Bulletin Board. As of March 29, 2026, the company’s close price was recorded at $0.3997. Over the past year, the stock has experienced significant volatility, with a 52-week high of $0.712 on October 26, 2025, and a 52-week low of $0.2052 on April 6, 2025. The company’s market capitalization stands at approximately $36,631,576 USD.
The financial metrics of Rocket Doctor AI Inc. reveal a challenging landscape. The price-to-earnings (P/E) ratio is currently at -2.786, indicating that the company is not generating positive earnings. This negative P/E ratio is a critical point of concern for investors, as it reflects the company’s ongoing struggle to achieve profitability.
Rocket Doctor AI Inc. operates in the healthcare technology sector, focusing on leveraging artificial intelligence to enhance treatment and patient care. Despite the innovative potential of its business model, the company has faced hurdles in translating its technological advancements into financial success. The fluctuating stock price and negative earnings underscore the challenges faced by the company in a competitive and rapidly evolving market.
Investors and stakeholders are closely monitoring Rocket Doctor AI Inc.’s strategic initiatives to improve its financial performance. The company’s ability to navigate these challenges and capitalize on its AI-driven solutions will be crucial in determining its future trajectory in the healthcare technology industry.
